Rodman David Malcom
SEC CIK 1672659 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| MLYS | Mineralys Therapeutics, Inc. | Chief Medical Off | 53.6K | — | $19.98M | 84 | 2023-08-10 | 2026-08-10 |
Most active insiders at MLYS, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Catalys Pacific Fund, LP | 10% | — | $43.35M |
| 2 | Congleton Jon | CEO, Dir | — | $14.91M |
| 3 | Rodman David Malcom | Chief Medical Off | — | $14.41M |
| 4 | Shah Rajeev M. | Dir | $8.76M | — |
| 5 | Levy Adam Scott | CFO, Sec | — | $6.16M |
| 6 | Warren Eric | Chief Commercial Off | — | $3.30M |
| 7 | Gold Alexander M | Dir | — | $1.58M |
| 8 | Karydas Daphne | Dir | — | $925.6K |
| 9 | Slingsby Brian Taylor | Dir, 10% | — | — |
| 10 | DiRocco Derek | Dir | — | — |
Transactions 84
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DT | 2026-08-12 19:33 | 2026-08-10 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,170 | 53.6K | +4% | +$34.7K |
| DT | 2026-08-12 19:33 | 2026-08-10 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.09 | -2,170 | 51.4K | -4% | -$58.8K |
| DT | 2026-07-20 21:00 | 2026-07-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 51.8K | +0.8% | +$6,423 |
| DT | 2026-07-20 21:00 | 2026-07-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.53 | -416 | 51.4K | -0.8% | -$11.0K |
| DMT | 2026-07-15 20:58 | 2026-07-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 71.8K | +24% | +$102.4K |
| DMT | 2026-07-15 20:58 | 2026-07-13+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.28 | -20.4K | 51.4K | -28% | -$556.7K |
| DT | 2026-07-10 19:15 | 2026-07-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 59.9K | +4% | +$34.7K |
| DT | 2026-07-10 19:15 | 2026-07-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $30.30 | -2,171 | 57.7K | -4% | -$65.8K |
| DMT | 2026-06-17 21:18 | 2026-06-15+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.55 | +8,126 | 61.7K | +15% | +$101.9K |
| DMT | 2026-06-17 21:18 | 2026-06-15+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $24.19 | -14.5K | 57.1K | -20% | -$350.1K |
| DMT | 2026-06-12 18:04 | 2026-06-10+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $4.88 | +8,519 | 69.8K | +14% | +$41.6K |
| DMT | 2026-06-12 18:04 | 2026-06-10+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $24.20 | -8,519 | 63.4K | -12% | -$206.2K |
| DT | 2026-05-19 19:15 | 2026-05-18 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 63.9K | +0.7% | +$6,438 |
| DT | 2026-05-19 19:15 | 2026-05-18 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.55 | -417 | 63.4K | -0.7% | -$11.5K |
| DMT | 2026-05-13 21:42 | 2026-05-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $8.45 | +16.2K | 77.5K | +26% | +$137.1K |
| DMT | 2026-05-13 21:42 | 2026-05-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $28.91 | -22.6K | 63.4K | -26% | -$652.6K |
| DT | 2026-04-21 18:59 | 2026-04-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 70.2K | +0.6% | +$6,423 |
| DT | 2026-04-21 18:59 | 2026-04-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $31.33 | -416 | 69.8K | -0.6% | -$13.0K |
| DMT | 2026-04-15 21:45 | 2026-04-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 90.2K | +18% | +$102.4K |
| DMT | 2026-04-15 21:45 | 2026-04-13+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.89 | -20.4K | 69.8K | -23% | -$548.7K |
| DT | 2026-04-13 21:13 | 2026-04-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,170 | 78.3K | +3% | +$34.7K |
| DT | 2026-04-13 21:13 | 2026-04-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.38 | -2,170 | 76.1K | -3% | -$59.4K |
| D | 2026-03-17 | 2026-03-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $25.65 | -417 | 76.1K | -0.5% | -$10.7K |
| D | 2026-03-17 | 2026-03-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 76.6K | +0.5% | +$6,438 |
| DM | 2026-03-16 | 2026-03-12+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.61 | -20.4K | 82.5K | -20% | -$543.0K |
| DM | 2026-03-16 | 2026-03-12+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 86.0K | +20% | +$102.4K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 84.7K | +3% | +$34.7K |
| D | 2026-03-10 | 2026-03-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $26.84 | -2,171 | 82.5K | -3% | -$58.3K |
| D | 2026-02-20 | 2026-02-19 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | A - Grant | $0.00 | +38.4K | 82.5K | +87% | $0 |
| D | 2026-02-17 | 2026-02-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.59 | -417 | 44.1K | -0.9% | -$11.5K |
| D | 2026-02-17 | 2026-02-17 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +417 | 44.5K | +0.9% | +$6,438 |
| DM | 2026-02-13 | 2026-02-12+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $27.93 | -20.4K | 51.0K | -29% | -$569.8K |
| DM | 2026-02-13 | 2026-02-12+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $7.28 | +14.1K | 56.8K | +33% | +$102.3K |
| D | 2026-02-11 | 2026-02-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $30.21 | -2,171 | 50.4K | -4% | -$65.6K |
| D | 2026-02-11 | 2026-02-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $16.00 | +2,171 | 52.6K | +4% | +$34.7K |
| D | 2026-01-20 | 2026-01-20 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.10 | -416 | 50.4K | -0.8% | -$13.4K |
| D | 2026-01-20 | 2026-01-20 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $15.44 | +416 | 50.9K | +0.8% | +$6,423 |
| DM | 2026-01-15 | 2026-01-13+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.67 | -19.1K | 50.4K | -27% | -$623.1K |
| DM | 2026-01-15 | 2026-01-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.39 | +7,709 | 65.3K | +13% | +$95.5K |
| DM | 2026-01-13 | 2026-01-09+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $4.88 | +8,518 | 64.0K | +15% | +$41.6K |
| DM | 2026-01-13 | 2026-01-09+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $32.56 | -8,518 | 61.8K | -12% | -$277.4K |
| DM | 2026-01-06 | 2026-01-02+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $12.27 | +252.7K | 97.2K | New | +$3.10M |
| DM | 2026-01-06 | 2026-01-02+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $35.25 | -262.8K | 115.3K | -70% | -$9.26M |
| 2025-10-15 | 2025-10-15 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale | $43.01 | -10.4K | 71.2K | -13% | -$446.0K | |
| M | 2025-09-16 | 2025-09-15 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale | $36.00 | -11.4K | 81.5K | -12% | -$409.3K |
| D | 2025-08-14 | 2025-08-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 104.3K | +6% | +$6,857 |
| D | 2025-08-14 | 2025-08-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $12.93 | -11.4K | 92.9K | -11% | -$146.9K |
| D | 2025-07-15 | 2025-07-14 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.59 | -11.4K | 97.9K | -10% | -$165.8K |
| D | 2025-07-15 | 2025-07-14 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 109.3K | +6% | +$6,857 |
| D | 2025-06-16 | 2025-06-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.60 | -11.4K | 101.7K | -10% | -$165.9K |
| D | 2025-06-16 | 2025-06-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 113.0K | +6% | +$6,856 |
| 2025-05-15 | 2025-05-14 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale | $15.29 | -11.4K | 106.7K | -10% | -$173.8K | |
| D | 2025-05-13 | 2025-05-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 118.0K | +6% | +$6,857 |
| D | 2025-04-15 | 2025-04-14 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 123.1K | +5% | +$6,856 |
| DM | 2025-04-15 | 2025-04-14 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $14.53 | -11.4K | 111.7K | -9% | -$165.2K |
| D | 2025-04-03 | 2025-04-01 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +1,606 | 172.5K | +0.9% | +$1,734 |
| DM | 2025-04-03 | 2025-04-01 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.76 | -55.8K | 116.7K | -32% | -$879.1K |
| D | 2025-03-13 | 2025-03-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,349 | 170.9K | +4% | +$6,857 |
| D | 2025-02-13 | 2025-02-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +6,348 | 164.5K | +4% | +$6,856 |
| DM | 2025-01-15 | 2025-01-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 158.2K | +8% | +$9,567 |
| D | 2024-12-13 | 2024-12-11 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,017 | 146.0K | +4% | +$2,709 |
| DM | 2024-11-12 | 2024-11-11 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8102 | +10.0K | 146.0K | +7% | +$8,137 |
| D | 2024-11-12 | 2024-11-11 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -5,026 | 141.0K | -3% | -$75.4K |
| D | 2024-11-08 | 2024-11-06 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +25.5K | 161.5K | +19% | +$27.5K |
| D | 2024-11-08 | 2024-11-06 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.03 | -25.5K | 136.0K | -16% | -$383.0K |
| DM | 2024-10-15 | 2024-10-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8187 | +10.4K | 130.6K | +9% | +$8,489 |
| DM | 2024-09-12 | 2024-09-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 125.6K | +10% | +$9,567 |
| DM | 2024-08-13 | 2024-08-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 114.2K | +11% | +$9,565 |
| D | 2024-07-18 | 2024-07-16 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +525 | 103.4K | +0.5% | +$567 |
| D | 2024-07-18 | 2024-07-16 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -525 | 102.9K | -0.5% | -$7,875 |
| DM | 2024-07-12 | 2024-07-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 102.9K | +12% | +$9,566 |
| DM | 2024-06-13 | 2024-06-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 89.7K | +15% | +$9,566 |
| DM | 2024-05-15 | 2024-05-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 78.4K | +17% | +$9,566 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $1.08 | +100 | 67.1K | +0.1% | +$108 |
| D | 2024-05-10 | 2024-05-09 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $15.00 | -100 | 67.0K | -0.1% | -$1,500 |
| DM | 2024-04-15 | 2024-04-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 67.0K | +20% | +$9,566 |
| DM | 2024-03-13 | 2024-03-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 55.6K | +26% | +$9,565 |
| DM | 2024-02-13 | 2024-02-12 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 37.9K | +43% | +$9,566 |
| DM | 2024-01-12 | 2024-01-11+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.8416 | +11.4K | 32.9K | +53% | +$9,565 |
| D | 2023-12-12 | 2023-12-11 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,018 | 20.1K | +33% | +$2,710 |
| D | 2023-11-14 | 2023-11-13 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +5,017 | 15.1K | +50% | +$2,709 |
| D | 2023-11-07 | 2023-11-03 | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.54 | +10.0K | 10.0K | New | +$5,418 |
| DM | 2023-08-11 | 2023-08-10+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | M - OptEx | $0.7175 | +231.7K | 76.2K | New | +$166.3K |
| DM | 2023-08-11 | 2023-08-10+ | MLYS | Mineralys Therapeutics, Inc. | Rodman David Malcom | Chief Medical Off | S - Sale+OE | $12.92 | -231.7K | 0 | -100% | -$2.99M |
Purchase Sale Sale after option exercise All abbreviations